BL-B01D1
Based on 1 Customer Validation
BL-B01D1 is a bispecific ADC, which targets EGFR and HER3 through bispecific antibody Izalontamab (HY-P99676), and exhibits cytotoxicity against various cancer cells via inhibition of DNA replication and DNA synthesis by its ADC toxin ED04 (HY-153891). BL-B01D1 can be used in the study of cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.65%
- Peso molecular:205830.00
-
Almacenamiento:
-80°C, protect from light
Ver todos los productos específicos de isoformas EGFR
More
Actividad biológica
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
Appearance Liquid
-
Peso molecular 205830.00
-
Color Colorless to light yellow
-
SMILES
[BL-B01D1]
-
Synonyms
Izalontamab Brengitecan
-
Envío
Shipping with dry ice.
-
Almacenamiento
-80°C, protect from light
Pureza y Documentación
-
Ficha de datos (265 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)